VIVO - Meridian Bioscience, Inc

Healthcare - Sector
Coverage Rating Distribution Performance Price Targets & Ratings Chart

VIVO is currently covered by 1 analysts with average potential upside of $4.91 (23.76%) backed by 25 price targets and 24 ratings. Documented since 27-Jul-2012. Analyst's average stock valuation to be materialised ratio is 77.78% with an average time for price targets to be met of 239 days.

Most recent stock forecast was given by YI CHEN from HCWAINWRIGHT on 08-Jul-2022.

Highest price target for VIVO is 33, Lowest price target is 19, average price target is 26.

Best performing analysts who are covering VIVO - Meridian Bioscience, Inc:

Yi Chen Steven Mah Mark Massaro

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

34

$0.03 (0.09%)

30

8 months 15 days ago

6/9 (66.67%)

$7.46 (35.31%)

337

Buy

34

$0.03 (0.09%)

34

2 years 1 months ago

4/6 (66.67%)

$6.09 (29.34%)

76

Sell

9

$-24.97 (-73.51%)

11

3 years 10 months 22 days ago

9/9 (100%)

$1.19 (6.64%)

304

Show more analysts